Reach patients in Europe you never thought possible
Rare diseases know no borders. Neither do we. That’s why we help connect global patients with life-changing rare and orphan disease treatments – and turn the challenges of European expansion into real opportunities.
Expertise
Scalability
Local access
Multilingual team
See how we work
Driven by our expertise in the rare disease space
We sit at the critical intersection of patients and their medicine. Our expertise across clinical care, logistics, nursing support, and patient technology helps improve health outcomes and quality of life.
0
units of orphan medicine supplied, reaching even the most hard-to-access patients
0
patients a year served with access to beneficial treatments and candidate therapies
€ 0 m
of orphan drugs bought and sold per year, including 50 different products across rare diseases
As a strategic partner, they have exceeded our expectations by finding European patients, who need our drugs, and enabling them to receive their life-extending medications
Chief Commercial Officer at leading US Biotech company
Our end-to end solution
We offer a 3-step solution to help meet the specific challenges of launching and delivering orphan drugs: find patients, access patients, and support patients. Our tailored, end-to-end approach helps ensure that patients can access innovative therapies safely and quickly and receive ongoing support.
Take your rare and orphan disease treatments across borders
Be part of the European rare disease market expansion. Our team is ready to offer a complimentary consultation, showing you exactly how we can help you scale across European markets and meet your specific business needs.
Meet our experts
Director, Rare Clinical Services
Mathieu Loiseau
Read more aboutMathieu Loiseau
With a background in adult nursing and experience in cancer, homecare, and patient support across Europe, Mathieu leads patient-centric programs and observational studies.
Vice President, Business Development
Andrew Cummins
Read more aboutAndrew Cummins
Andrew has 30+ years of experience in senior international commercial leadership positions within the Pharmaceuticals and Medical Devices sectors.
Vice President, Medical Affairs
Alastair MacDonald
Read more aboutAlastair MacDonald
Alastair has 30+ years of experience in the biopharmaceutical development of pre and post approval drugs.
Vice President, Rare Disease Strategy
Ray Huml
Read more aboutRay Huml
Ray has over 25 years of experience in the healthcare and biopharmaceutical industries, having spent over 20 years at IQVIA.
Financial health
Licensing
Tailored approach
Discover more resources
Thought Leadership
Navigating early access in Europe: a strategic blueprint for biotech leaders
Thought Leadership
The impact of real-world data in gaining access to the European orphan drugs market.
Thought Leadership
Launching successful patient support programs for rare disease patients across Europe
Get in touch to book a meeting
To discuss your challenges and create a strategy for accessing Europe tailored to your business needs, please complete the form below. Our commercial team will contact you to schedule a meeting and provide a complimentary consultation to support your specific requirements.